HVIP Outcomes and Stakeholder Insights
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16+
SponsorMedical University of South Carolina
About this trial
The study's goal is to perform an evaluation of a Southeastern hospital violence intervention program (HVIP) that includes comprehensive patient outcomes, perceived benefits and opportunities for improvement of an HVIP from the perspectives of multiple stakeholders including patients, family members and healthcare providers.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients ages 16 and above treated at MUSC Charleston that experience an injury due to interpersonal or community violence
Glasgow coma score (GCS) of 15 at the time of study enrollment
Disqualifiers
Lack of capacity to consent due to altered mental status (AMS) or severe untreated mental illness
Being under arrest or incarcerated at the time of assessment for enrollment
Non-English speaking patients
Ages under 16
Trial design
Design model
Single group
Treatments tested in this trial
Turning the Tide Violence Intervention Program (hospital violence intervention program)
BehavioralTTVIP is already integrated into the regular care of patients who are violently injured and treated at MUSC Charleston. Client advocates provide immediate support, help with communication and provide anti-retaliation messaging to victims of violence and their families, in addition to helping support their healthcare. Patients that opt to be followed for long-term wrap-around services and live in the surrounding 3-county area are supported for months (up to 1 year) after injury and provided mentorship, service referrals (i.e. education, employment, substance abuse, injury recovery, pro-social activities, housing) and mental health services.
Treatment groups
220 Participants
are divided into 1 treatment groupGroup A: Patients, family members and healthcare providersOther 1 intervention
Trial outcomes
Primary outcomes
1
Post Traumatic Stress Disorder
PTSD: PTSD Checklist for DSM-5 (PCL) The PCL-5 is a 20-item questionnaire, corresponding to the DSM-5 symptom criteria for PTSD. The self-report rating scale is 0-4 for each symptom. Rating scale descriptors are the same: Not at all, A little bit, Moderately, Quite a bit, and Extremely. They are scored 0-4. The score is totaled (0-80), with a cut-off of 33 being indicative of PTSD and higher scores indicating worse symptoms.
Time frame
Victims of violence will be screened at baseline enrollment, 3 months, 6 months and 12 months after enrollment2
Self-Esteem
Self esteem will be assessed using he Rosenberg Self Esteem Scale. This is a 10-item scale with response options that indicate level of agreement (strongly agree, agree, disagree, strongly disagree) related to statements of self esteem. Responses are scored (1-4), and totaled. Higher scores indicate higher self-esteem.
Time frame
Victims of violence will be assessed at baseline, 3 months, 6 months and 12 months3
Future Firearm Violence Risk
Future risk of firearm violence will be assessed with the SaFTEy Score (Serious fighting, Friend weapon carrying, community Environment, and firearm Threats). This is a 4 -item survey that assesses future risk of experiencing firearm violence. Each response is scored and all are totaled. Scores range 0-10, and 10 indicates high risk of future violence.
Time frame
Victims of violence will be assessed at baseline, 3 months, 6 months and 12 months after enrollment.4
Depression
The PHQ-9 (patient health questionnaire) is used to assess for depression. It is a 9 item instrument that asks about depressive symptoms. Each question has a 4 response option that assesses for frequency of having symptoms, and each question is scored 0-3. The total score ranges from 0-27. 0 - 4 indicates no depression, 5-9 mild depressive symptoms, 10-14 moderate depressive symptoms, 15-19 moderately-severe depressive symptoms, and 20-27 severe depressive symptoms.
Time frame
Victims of violence will be assessed at baseline enrollment, 3 months, 6 months and 12 months after enrollment.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Medical University of South Carolina
Lead sponsor
Kaiser Permanente
Collaborator
Source ClinicalTrials.gov